PHILLY FIGHTS CANCER

Philly Fights Cancer was founded in 2015 and acts as the Abramson Cancer Center’s main fundraising channel, bringing both awareness and funding to the center’s translational research and clinical trials.  The Abramson family, consisting of the founding generation, their children, and grandchildren, have committed themselves to spreading the word about the astounding work being done in Philadelphia, and to ensuring that there are continuing efforts to fund the brilliant researchers and clinicians.  Philly Fights Cancer has attracted support of major corporations and philanthropists who share the Abramson’s passion and commitment. Philly Fights Cancer is helping to continue the compassionate treatment and the medical innovation that Abramson Cancer Center has become known and internationally recognized for.

For more information on sponsorship opportunities, please visit here.

ABRAMSON CANCER CENTER

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. The Center’s preeminent position is reflected in its continuous designation as a Comprehensive Cancer Center by the National Cancer Institute since 1973, one of 47 such Centers in the United States.

At the Abramson Cancer Center, physicians are dedicated to innovative and compassionate cancer care. The clinical program, comprised of a dedicated staff of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists, and patient care coordinators, currently sees over 90,000 outpatient visits, over 11,800 inpatient discharges, and provides over 37,000 chemotherapy treatments, and more than 66,000 radiation treatments.

Not only is the Abramson Cancer Center dedicated to providing state-of-the-art cancer care, the latest forms of cancer prevention, diagnosis, and treatment are available to patients through clinical themes that developed in the relentless pursuit to eliminate the pain and suffering from cancer.

In addition, the Abramson Cancer Center is home to the 400+ basic, translational, and clinical scientists who work relentlessly to determine the pathogenesis of cancer. The Abramson Cancer Center is committed to improving the prevention, diagnosis, and treatment of cancer.